Air Force Research Laboratory


Biochemistry & Structural Biology

  • Bernard Fongang, Ph.D. – Computational tools to study genetic and environmental factors in
    Alzheimer’s Disease and other neurodegenerative disorders
  • Xianlin Han, Ph.D. – Sulfatide and myelin lipids in pathogenesis of Alzheimer’s Disease and aging
  • Jean Jiang, Ph.D. – Connexins in gap junction and hemichannel function and dysfunction
  • Oleg Klykov, Ph.D. – Structural regulation of glutamate receptor function
  • David Libich, Ph.D. – Biomolecular interactions of RNA-binding proteins in neurodegenerative processes
  • Bruce Nicholson, Ph.D. – Connexins in gap junction function and pathophysiology

Cell Systems & Anatomy

Cellular & Integrative Physiology


Glen Biggs Institute for Alzheimer’s and Neurodegenerative Diseases

Mays Cancer Center


Microbiology, Immunology & Molecular Genetics

Military Health Institute

  • Jeremy Nelson, Ph.D. – Human performance and brain injury

Molecular Medicine




Oral and Maxillofacial Surgery

  • Nathan Jeske, Ph.D. – Biochemical signaling mechanisms in inflammatory pain and analgesia
  • Yu Shin Kim, Ph.D. – Regulation of sensory modalities including pain, itch and gentle touch

Pathology and Laboratory Medicine

  • Margaret Flanagan, Ph.D. – Use of human brain tissue to identify disease mechanisms, risk factors and protective factors for dementia



  • Kelly Berg, Ph.D. – G protein – coupled receptors, signal transduction, ligand functional selectivity
  • Flavia Carreno, Ph.D. – Psychopharmacology; novel therapies for treatment-resistant depression
  • Bill Clarke, Ph.D. – Molecular and cellular mechanisms of drug efficacy and functional selectivity
  • Greg Collins, Ph.D. – Determinants of drug-seeking and drug-taking of abused substances
  • Teresa Evans, Ph.D. – Student stress and mental health; K-12 STEM education
  • Charles France, Ph.D. – Behavioral and pharmacological factors in the abuse liability of drugs
  • Alan Frazer, Ph.D. – Mechanism of action of novel antidepressant drugs
  • Milena Girotti, Ph.D. – Impact of stress on behavior mediated in the orbitofrontal cortex
  • Sarah Hopp, Ph.D. – Role of microglia in neurodegeneration; inflammation in Alzheimer’s Disease
  • Noboru Hiroi, Ph.D. – Genetic, cellular and molecular mechanisms of developmental neuropsychiatric disorders
  • Sheela Kadapakkam, Ph.D. – Regulation of aldehyde detoxification in Parkinson’s Disease
  • Jing Liu, Ph.D. – Neurobiology of stress-related psychiatric disorders and their treatment
  • Daniel Lodge, Ph.D. – Systems level study of psychiatric disorders and treatment in animal models
  • Liang Ma, Ph.D. – Functional genomics of neuropsychiatric and neurologic diseases; human iPS cell models
  • David Morilak, Ph.D. – Mechanisms of stress-induced behavioral pathology and its treatment
  • David Maguire, Ph.D. – Behavioral pharmacology; abuse potential of drugs; treatment of substance use disorders
  • Jason O’Connor, Ph.D. – Neuroimmunology; mechanisms linking inflammation and depression
  • James Roberts, Ph.D. – Neuroprotection and neurodegeneration in aging
  • Gek-Ming Sia, Ph.D. – Neurodevelopment; mechanisms of synapse formation and elimination
  • Randy Strong, Ph.D. – Role of catecholamines in neurodegeneration and aging; regulation of tyrosine hydroxylase gene expression

Physical Therapy

Psychiatry & Behavioral Sciences

Rehabilitation Medicine

Research Imaging Institute